Serum lipids in power athletes self-administering XXXX and anabolic @entity230 .

@entity251 @entity9478 @entity342 @entity9477 @entity230 @entity3800 @entity165
The purpose of the present investigation was to study the effects of @entity251 and anabolic @entity230 on serum lipids in power athletes. Altogether 11 national top-level adult athletes completed the study. Five of them volunteered for the study group and the rest for controls. The follow-up consisted of 9 months of a strength training period. During the first 6 months, the subjects in the study group self-administered androgenic @entity230 on an average of 57 +/- 24.9 mg/day. The most interesting observation was the extremely low high-density lipoprotein (HDL) and @entity9477 @entity165 concentrations of the @entity342 users. After 8 weeks of training, the study group had significantly (P less than 0.05) lower HDL @entity165 concentrations than the control group (0.53 +/- 0.11 and 1.14 +/- 0.19 mmol/l, respectively). This difference remained significant from 8 to 32 weeks of training. No systematic changes were observed in the control group. The @entity9477 @entity165 concentration decreased by about 80% (P less than 0.01) and @entity9478 @entity165 by about 55% (P less than 0.01) from the onset values in the study group. A substantial decrease in HDL @entity165 to total @entity165 and in @entity9477 @entity165 to @entity9478 @entity165 ratios were also noticed under the influence of exogenous @entity3800 . The results of this study suggest that the sustained use of @entity251 and anabolic @entity230 have a marked unfavorable effect on the pattern of HDL @entity165 in the serum of male power athletes.
